Literature DB >> 12360391

Increased angiogenic growth factor in cyanotic congenital heart disease.

W Himeno1, T Akagi, J Furui, Y Maeno, M Ishii, K Kosai, T Murohara, H Kato.   

Abstract

To examine the relationship between the plasma levels of angiogenic growth factors and the severity of cyanosis, 80 patients with cyanotic heart disease (CHD) and 81 healthy controls were studied. Median age and mean arterial blood oxygen saturation respectively were 4.2 years and 81% in CHD subjects and 4.8 years and 98% in controls. Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) were measured in plasma using enzyme-linked immunoassay. Plasma VEGF levels in controls depended negatively on age (p < 0.0001) until 3 months, when VEGF was no longer elevated. No such age dependence was found for HGF. Although VEGF levels did not differ between CHD and control subjects up to the age of 3 months, VEGF was significantly elevated in CHD patients older than 3 months compared to controls of similar age (149 +/- 106 vs 65 +/- 23 pg/ml, p < 0.0001). Moreover, the VEGF levels were negatively correlated with oxygen saturation (p = 0.03) and positively correlated with hemoglobin (p = 0.004) in CHD patients aged between 3 months and 10 years. Although the physiologic elevation of VEGF in the neonatal period decreases rapidly if oxygen saturation is normal, VEGF elevations persist if systemic hypoxia is present.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12360391     DOI: 10.1007/s00246-002-0266-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  6 in total

1.  Systemic-to-pulmonary collateral flow, as measured by cardiac magnetic resonance imaging, is associated with acute post-Fontan clinical outcomes.

Authors:  Andrew C Glatz; Jonathan J Rome; Adam J Small; Matthew J Gillespie; Yoav Dori; Matthew A Harris; Marc S Keller; Mark A Fogel; Kevin K Whitehead
Journal:  Circ Cardiovasc Imaging       Date:  2012-01-06       Impact factor: 7.792

2.  Characterizing the angiogenic activity of patients with single ventricle physiology and aortopulmonary collateral vessels.

Authors:  Nefthi Sandeep; Yutaka Uchida; Kanishka Ratnayaka; Robert McCarter; Sridhar Hanumanthaiah; Aminata Bangoura; Zhen Zhao; Jacqueline Oliver-Danna; Linda Leatherbury; Joshua Kanter; Yoh-Suke Mukouyama
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-09       Impact factor: 5.209

3.  Angiogenic biomarkers in children with congenital heart disease: possible implications.

Authors:  Nagla T El-Melegy; Nagwa A Mohamed
Journal:  Ital J Pediatr       Date:  2010-04-20       Impact factor: 2.638

4.  Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass.

Authors:  John S Giuliano; Patrick M Lahni; Michael T Bigham; Peter B Manning; David P Nelson; Hector R Wong; Derek S Wheeler
Journal:  Intensive Care Med       Date:  2008-05-31       Impact factor: 17.440

5.  Anatomical features of the right internal jugular vein in infants and young children undergoing heart surgery for congenital disease: comparison between cyanotic and noncyanotic patients.

Authors:  Yuji Morimoto; Kenjiro Hisano; Koichi Takita; Toshikazu Hashimoto
Journal:  J Anesth       Date:  2008-02-27       Impact factor: 2.078

6.  Propofol Upregulates MicroRNA-30b to Inhibit Excessive Autophagy and Apoptosis and Attenuates Ischemia/Reperfusion Injury In Vitro and in Patients.

Authors:  Zhiqi Lu; Jiaojiao Shen; Xubin Chen; Zhihua Ruan; Weihua Cai; Shuyun Cai; Minjun Li; Yihui Yang; Jian Mo; Guixi Mo; Yan Lu; Jing Tang; Liangqing Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-03-30       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.